These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6102119)

  • 1. The effect of low- and high-humidity ageing on the hardness, disintegration time and dissolution rate of dibasic calcium phosphate-based tablets.
    Chowhan ZT
    J Pharm Pharmacol; 1980 Jan; 32(1):10-4. PubMed ID: 6102119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging of tablets made with dibasic calcium phosphate dihydrate as matrix.
    Lausier JM; Chiang CW; Zompa HA; Rhodes CT
    J Pharm Sci; 1977 Nov; 66(11):1636-7. PubMed ID: 915749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of storage at specified temperature and humidity on properties of three directly compressible tablet formulations.
    Horhota ST; Burgio J; Lonski L; Rhodes CT
    J Pharm Sci; 1976 Dec; 65(12):1746-9. PubMed ID: 1032656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disintegration properties of calcium phosphate dibasic dihydrate tablets.
    Khan KA; Rhodes CT
    J Pharm Sci; 1975 Jan; 64(1):166-8. PubMed ID: 1133695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Water-sorption properties of tablet disintegrants.
    Khan KA; Rhodes CT
    J Pharm Sci; 1975 Mar; 64(3):447-51. PubMed ID: 1151632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of formulation solubility and hygroscopicity on disintegrant efficiency in tablets prepared by wet granulation, in terms of dissolution.
    Johnson JR; Wang LH; Gordon MS; Chowhan ZT
    J Pharm Sci; 1991 May; 80(5):469-71. PubMed ID: 1880728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of binders in moisture-induced hardness increase in compressed tablets and its effect on in vitro disintegration and dissolution.
    Chowhan ZT
    J Pharm Sci; 1980 Jan; 69(1):1-4. PubMed ID: 7354417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hardness on the disintegration time and the dissolution rate of uncoated caffeine tablets.
    Kitazawa S; Johno I; Ito Y; Teramura S; Okado J
    J Pharm Pharmacol; 1975 Oct; 27(10):765-70. PubMed ID: 241790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive evaluation of pharmaceutical properties of direct compression tablets containing theophylline anhydrate during storage at high humidity by near-infrared spectroscopy.
    Otsuka Y; Yamamoto M; Tanaka H; Otsuka M
    Biomed Mater Eng; 2015; 25(3):223-36. PubMed ID: 26407109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hardness increase induced by partial moisture loss in compressed tablets and its effect on in vitro dissolution.
    Chowhan ZT; Palagyi L
    J Pharm Sci; 1978 Oct; 67(10):1385-9. PubMed ID: 702286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some formulation factors affecting the tensile strength, disintegration and dissolution of uncoated oxytetracycline tablets.
    Esezobo S; Pilpel N
    J Pharm Pharmacol; 1976 Jan; 28(1):8-16. PubMed ID: 6662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in the Dissolution Behaviors of Tablets Containing Polyvinylpolypyrrolidone (PVPP) Depending on Pharmaceutical Formulation After Storage Under High Temperature and Humid Conditions.
    Takekuma Y; Ishizaka H; Sumi M; Sato Y; Sugawara M
    J Pharm Pharm Sci; 2016; 19(4):511-519. PubMed ID: 28057169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of moisture content, temperature and exposure time on the physical stability of chitosan powder and tablets.
    Viljoen JM; Steenekamp JH; Marais AF; Kotzé AF
    Drug Dev Ind Pharm; 2014 Jun; 40(6):730-42. PubMed ID: 23596972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of generic preparations of famotidine orally disintegrating tablets for use in unit-dose packages.
    Yamazaki N; Iizuka R; Miyazawa S; Wada Y; Shimokawa K; Ishii F
    Drug Discov Ther; 2012 Oct; 6(5):263-8. PubMed ID: 23229147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium phosphates in pharmaceutical tableting. 2. Comparison of tableting properties.
    Schmidt PC; Herzog R
    Pharm World Sci; 1993 Jun; 15(3):116-22. PubMed ID: 8348107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets.
    Late SG; Yu YY; Banga AK
    Int J Pharm; 2009 Jan; 365(1-2):4-11. PubMed ID: 18778759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of humidity on the disintegrant property of alpha-cellulose.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2005; 62(1):39-44. PubMed ID: 16022492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of nilvadipine solid dispersion to tablet formulation and manufacturing using crospovidone and methylcellulose as dispersion carriers.
    Hirasawa N; Ishise S; Miyata H; Danjo K
    Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):244-7. PubMed ID: 14758011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the mode of super disintegrant incorporation on dissolution in wet granulated tablets.
    Gordon MS; Rudraraju VS; Dani K; Chowhan ZT
    J Pharm Sci; 1993 Feb; 82(2):220-6. PubMed ID: 8445539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Use of Magnesium Oxide as an Excipient to Maintain the Hardness of Orally Disintegrating Tablets during Unpackaged Storage.
    Sakamoto T; Kachi S; Nakamura S; Yuasa H
    Chem Pharm Bull (Tokyo); 2019; 67(3):284-288. PubMed ID: 30828006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.